Status:
UNKNOWN
Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Skin Abnormality
Eligibility:
All Genders
18-80 years
Phase:
EARLY_PHASE1
Brief Summary
Existing methods of diagnosing and treating skin lesions are either surgical, which enables an histological diagnosis or destructive (electrodesiccation, liquid nitrogen, laser, caustics) with no poss...
Detailed Description
The formulations are comprised of standard non-toxic laboratory chemicals that are used in various dermatological preparations. Transition metal salts - Zinc chloride, zinc bromide, zinc iodide,zinc ...
Eligibility Criteria
Inclusion
- Patients with skin lesions that are not treated with histology
Exclusion
- Seriously ill patients
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01176994
Start Date
December 1 2010
End Date
May 1 2012
Last Update
August 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100